As per our report, the global clinical decision support systems market size is expected to reach USD 2199.13 million by 2029 and USD 1259.05 million in 2024. It is sprinting at a CAGR of 11.8% during the forecast period. The market is experiencing relatively more significant growth in health, IT budgets, and health markets. The clinical decision-making system worldwide is increasing with the care rule, and the increase in primary health care will likely boost market growth.
Clinical decision support is a clinical and practical tool that helps improve the operational efficiency of health practices. Hospitals and clinics must deal with enormous clinical and clinical information. To handle the large volume of data, medical professionals and reception staff are always looking for an efficient way to record, store, and improve access to patient information.
The United States Food and Drug Administration (FDA) has announced regulatory approval for the Viz.AI application, the first clinical decision support (CDS) based on artificial intelligence. Of the world, which was approved for sale in the United States. Viz.AI Contact is used to analyze the results of computed tomography (CT).
Clinical decision support is a clinical and practical tool that helps improve the operational efficiency of health practices. Hospitals and clinics must deal with enormous clinical and clinical information. To handle the large volume of data, medical professionals and reception staff are always looking for an efficient way to record, store, and improve access to patient information—the support system for the clinical decision and the patient's clinical workflow. The physics recommendations for systems and systems can also accelerate the market growth of clinical decision support systems. These factors are projected soon to boost the demand for a clinical decision support system. Also, advances in the development of a system to support clinical decisions.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Component, Delivery Mode, Product, Type, Model, User Intractability, Application, Setting, Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Market Leaders Profiled |
Wolters Kluwer Health (USA), Hearst Health (USA), and Elsevier B.V. |
North America dominated the CDSS market and is expected to continue dominating throughout the forecast period. The growth of the North American market is primarily driven by factors such as technologically advanced research and diagnostic treatment platforms for chronic diseases, the presence of many reimbursement policies, the strengthening of health infrastructure in Canada, and the development of IT health organizations in North America. Besides, the number of GP surgeries in the United States has increased, which should help drive the expansion of the US cloud-based clinical decision support system over the forecast period. The U.S. CDSS market accounted for the dominating share of the North American region in 2023, followed by Canada.
The European CDSS market is estimated to grow at a healthy CAGR in the coming years and hold decent occupancy in the global market during the forecast period.
The APAC CDSS market is expected to be the fastest-growing region for clinical decision support systems over the forecast period. On the other hand, in the Asia-Pacific region, China dominated the market for clinical decision support systems, while India is expected to grow exponentially over the forecast period.
The CDSS market in Latin America is predicted to grow steadily during the forecast period.
The MEA CDSS market is projected to hold a moderate share of the worldwide market in the coming years.
Wolters Kluwer Health (USA), Hearst Health (USA), and Elsevier B.V. (Netherlands) are the leading players in the market. Other key players include Cerner Corporation (USA), McKesson Corporation (USA), Epic Systems Corporation (USA), MEDITECH (USA), Philips Healthcare (Netherlands) and International Business Machines (IBM) (USA), and Allscripts Healthcare Solutions, Inc. (USA).
This research report on the Global clinical decision support system (CDSS) market has been segmented and sub-segmented into the following categories.
By Component
By Delivery Mode
By Product
By Type
By Model
By User Interactivity
By Application
By Setting
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region